Sanofi says good results from flu vaccine with mRNA booster study
Sanofi, a French healthcare business, announced on Wednesday that the first research into a high-dose influenza vaccination with a COVID-19 mRNA booster had yielded good results. Sanofi stated initial findings from a trial comparing Sanofi’s Fluzone H...
7 October, 2021
Read more